JP2018524304A5 - - Google Patents

Download PDF

Info

Publication number
JP2018524304A5
JP2018524304A5 JP2017564668A JP2017564668A JP2018524304A5 JP 2018524304 A5 JP2018524304 A5 JP 2018524304A5 JP 2017564668 A JP2017564668 A JP 2017564668A JP 2017564668 A JP2017564668 A JP 2017564668A JP 2018524304 A5 JP2018524304 A5 JP 2018524304A5
Authority
JP
Japan
Prior art keywords
independently
hydrogen
case
cycloalkyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017564668A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018524304A (ja
JP7013245B2 (ja
Filing date
Publication date
Priority claimed from US14/742,544 external-priority patent/US9394227B1/en
Priority claimed from US14/829,180 external-priority patent/US9643911B2/en
Application filed filed Critical
Publication of JP2018524304A publication Critical patent/JP2018524304A/ja
Publication of JP2018524304A5 publication Critical patent/JP2018524304A5/ja
Priority to JP2021151659A priority Critical patent/JP2022003057A/ja
Application granted granted Critical
Publication of JP7013245B2 publication Critical patent/JP7013245B2/ja
Priority to JP2023209782A priority patent/JP2024019523A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017564668A 2015-06-17 2016-06-14 トレプロスチニル誘導体ならびにその組成物および使用 Active JP7013245B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021151659A JP2022003057A (ja) 2015-06-17 2021-09-17 トレプロスチニル誘導体ならびにその組成物および使用
JP2023209782A JP2024019523A (ja) 2015-06-17 2023-12-13 トレプロスチニル誘導体ならびにその組成物および使用

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201514742579A 2015-06-17 2015-06-17
US14/742,544 US9394227B1 (en) 2015-06-17 2015-06-17 Treprostinil derivatives and compositions and uses thereof
US14/742,544 2015-06-17
US14/742,579 2015-06-17
US14/829,180 US9643911B2 (en) 2015-06-17 2015-08-18 Treprostinil derivatives and compositions and uses thereof
US14/829,180 2015-08-18
PCT/US2016/037383 WO2016205202A1 (en) 2015-06-17 2016-06-14 Treprostinil derivatives and compositions and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021151659A Division JP2022003057A (ja) 2015-06-17 2021-09-17 トレプロスチニル誘導体ならびにその組成物および使用

Publications (3)

Publication Number Publication Date
JP2018524304A JP2018524304A (ja) 2018-08-30
JP2018524304A5 true JP2018524304A5 (cg-RX-API-DMAC7.html) 2019-07-11
JP7013245B2 JP7013245B2 (ja) 2022-01-31

Family

ID=56204034

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017564668A Active JP7013245B2 (ja) 2015-06-17 2016-06-14 トレプロスチニル誘導体ならびにその組成物および使用
JP2021151659A Pending JP2022003057A (ja) 2015-06-17 2021-09-17 トレプロスチニル誘導体ならびにその組成物および使用
JP2023209782A Pending JP2024019523A (ja) 2015-06-17 2023-12-13 トレプロスチニル誘導体ならびにその組成物および使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021151659A Pending JP2022003057A (ja) 2015-06-17 2021-09-17 トレプロスチニル誘導体ならびにその組成物および使用
JP2023209782A Pending JP2024019523A (ja) 2015-06-17 2023-12-13 トレプロスチニル誘導体ならびにその組成物および使用

Country Status (10)

Country Link
US (11) US9643911B2 (cg-RX-API-DMAC7.html)
EP (3) EP3310769B1 (cg-RX-API-DMAC7.html)
JP (3) JP7013245B2 (cg-RX-API-DMAC7.html)
KR (2) KR102711773B1 (cg-RX-API-DMAC7.html)
CN (1) CN108349926A (cg-RX-API-DMAC7.html)
CA (1) CA2989317A1 (cg-RX-API-DMAC7.html)
ES (2) ES2859749T3 (cg-RX-API-DMAC7.html)
HK (1) HK1258913A1 (cg-RX-API-DMAC7.html)
IL (4) IL305157B2 (cg-RX-API-DMAC7.html)
WO (1) WO2016205202A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
JP6542128B2 (ja) 2013-01-11 2019-07-10 コルセア ファーマ インコーポレイテッド トレプロスチニルのプロドラッグ
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9643911B2 (en) * 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
IL310250B2 (en) 2016-05-05 2025-09-01 Liquidia Tech Inc Terpostinil in dry powder form for the treatment of pulmonary hypertension
EP3515430A1 (en) 2016-09-26 2019-07-31 United Therapeutics Corporation Treprostinil prodrugs
US20190099383A1 (en) * 2017-09-30 2019-04-04 Samos Pharmaceuticals, Inc. Transdermal Delivery of Selexipag Metabolite
EP3498283A1 (en) * 2017-12-14 2019-06-19 Ipsol AG Glycosidic derivatives of treprostinil
EP4017588A1 (en) 2019-08-23 2022-06-29 United Therapeutics Corporation Treprostinil prodrugs
CN115916212A (zh) 2020-04-17 2023-04-04 联合治疗公司 曲前列尼尔用于治疗间质性肺病
CN117062605A (zh) 2020-12-14 2023-11-14 联合治疗公司 使用曲前列环素前药治疗疾病的方法
CN117479946A (zh) 2021-03-03 2024-01-30 联合治疗公司 含曲前列环素及其前药并还包含(e)-3,6-双[4-(n-羰基-2-丙烯基)酰胺丁基]-2,5-二酮哌嗪(fdkp)的干粉组合物
CN117015524A (zh) * 2021-03-16 2023-11-07 江苏恒瑞医药股份有限公司 一种曲前列环素衍生物及其用途
WO2023154705A1 (en) 2022-02-08 2023-08-17 United Therapeutics Corporation Treprostinil iloprost combination therapy
CN115894240B (zh) * 2022-10-14 2025-02-14 广州楷石医药有限公司 曲前列尼尔的前体药物及其应用
CN115448839B (zh) * 2022-10-14 2025-02-14 广州楷石医药有限公司 一种曲前列尼尔的前体药物
EP4652151A1 (en) * 2023-01-19 2025-11-26 United Therapeutics Corporation Treprostinil analogs
CN117800845A (zh) * 2023-03-28 2024-04-02 广州楷石医药有限公司 一种羟基取代曲前列尼尔衍生物、合成方法及其应用
TW202502721A (zh) * 2023-07-03 2025-01-16 香港商長風藥業(香港)有限公司 一種曲前列環素衍生物、其製備方法及應用

Family Cites Families (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US4144317A (en) 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4262003A (en) 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
US4201211A (en) 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
US4338457A (en) 1980-02-28 1982-07-06 The Upjohn Company Composition and process
US4525586A (en) 1980-02-28 1985-06-25 The Upjohn Company Composition and process
US4306075A (en) 1980-03-28 1981-12-15 The Upjohn Company Composition and process
US4420632A (en) 1980-04-15 1983-12-13 The Upjohn Company Composition and process
US4306076A (en) 1980-04-23 1981-12-15 The Upjohn Company Inter-phenylene CBA compounds
US4349689A (en) 1980-12-22 1982-09-14 The Upjohn Company Methano carbacyclin analogs
US4379454A (en) 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
DE3333240A1 (de) 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
US4668814A (en) 1984-03-08 1987-05-26 The Upjohn Company Interphenylene carbacyclin derivatives
US4683330A (en) 1984-03-08 1987-07-28 The Upjohn Company Interphenylene carbacyclin derivatives
GB8814438D0 (en) 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
GB8824187D0 (en) 1988-10-14 1988-11-23 Wellcome Found Compounds for use in medicine
US5088977A (en) 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
CA2056039A1 (en) 1991-01-22 1992-07-23 Philip L. Fuchs Carbacyclin analogs
US5234690A (en) 1991-08-23 1993-08-10 Cygnus Therapeutic Systems Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
US5869505A (en) 1993-02-02 1999-02-09 Keenan; Robert M. Nicotine metabolites and nicotine dependence
US5853751A (en) 1993-06-23 1998-12-29 Masiz; John J. Molecular transdermal transport system
US5797898A (en) 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
IN184589B (cg-RX-API-DMAC7.html) 1996-10-16 2000-09-09 Alza Corp
CN1354622A (zh) 1999-03-31 2002-06-19 联合治疗公司 前列腺素类化合物、组合物和治疗外周血管疾病和肺动脉高压的方法
WO2001052823A2 (en) 2000-01-20 2001-07-26 Noven Pharmaceuticals, Inc. Compositions to effect the release profile in the transdermal administration of drugs
US6242482B1 (en) 2000-06-05 2001-06-05 United Therapeutics Corporation Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure
US6635274B1 (en) 2000-10-27 2003-10-21 Biochemics, Inc. Solution-based transdermal drug delivery system
US6700025B2 (en) 2001-01-05 2004-03-02 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
US20030108512A1 (en) 2001-12-10 2003-06-12 Robert Shorr Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
CA2959852A1 (en) 2003-05-22 2005-01-27 United Therapeutics Corporation Compounds and methods for delivery of prostacyclin analogs
CA2530407A1 (en) * 2003-07-23 2005-02-03 The Regents Of The University Of California Penetration enhancer combinations for transdermal delivery
US7375139B2 (en) 2003-08-18 2008-05-20 Aldred Katherine M Transdermal method and apparatus
JP2005120069A (ja) 2003-10-13 2005-05-12 Anges Mg Inc 炎症性疾患治療薬
JP4906514B2 (ja) 2003-12-16 2012-03-28 ユナイテッド セラピューティクス コーポレイション 腎臓機能改善のためのトレプロスチニルの用途
ATE473736T1 (de) 2003-12-16 2010-07-15 United Therapeutics Corp Verwendung von treprostinil zur behandlung von ischämischen läsionen
DE602005020269D1 (de) 2004-04-12 2010-05-12 United Therapeutics Corp Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
WO2006015299A2 (en) 2004-07-30 2006-02-09 Microchips, Inc. Multi-reservoir device for transdermal drug delivery and sensing
WO2006044206A2 (en) 2004-10-08 2006-04-27 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
CN101212975A (zh) 2005-06-03 2008-07-02 艾克若克斯Dds有限公司 用于透皮给药的方法和组合物
EA200801369A1 (ru) 2005-12-20 2009-02-27 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы трансдермального введения агониста рецептора индолсеротонина и трансдермальные лекарственные формы для применения этого способа
PT1988910T (pt) 2006-02-28 2018-02-07 Kodiak Sciences Inc Acriloiloxietilfosforilcolina contendo conjugados de polímeros e sua preparação
US8747897B2 (en) 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
US20080200449A1 (en) 2006-05-15 2008-08-21 United Therapeutics Corporation Treprostinil administration using a metered dose inhaler
WO2008002929A2 (en) 2006-06-26 2008-01-03 Inverseon, Inc. Heterologous cross-sensitization for improved agonist activity
US20090036465A1 (en) 2006-10-18 2009-02-05 United Therapeutics Corporation Combination therapy for pulmonary arterial hypertension
CA2678258A1 (en) 2007-02-09 2008-08-14 United Therapeutics Corporation Treprostinil treatment for interstitial lung disease and asthma
BRPI0814105A2 (pt) 2007-07-11 2015-02-03 Lexicon Pharmaceuticals Inc Métodos e composições para o tratamento de hipertensão pulmonar e doenças e distúrbios relacionados
KR101898407B1 (ko) 2007-12-17 2018-09-12 유나이티드 세러퓨틱스 코오포레이션 레모둘린®의 활성 성분인 트레프로스티닐의 개선된 제조 방법
WO2009152160A1 (en) 2008-06-10 2009-12-17 Gilead Sciences, Inc. Inhaled carbaprostacyclin and prostacyclin prodrugs for the treatment of pulmonary arterial hypertension
WO2009158010A1 (en) 2008-06-27 2009-12-30 Concert Pharmaceuticals, Inc. Prostacyclin analogs
PT2315587T (pt) 2008-08-13 2018-01-31 Actelion Pharmaceuticals Ltd Produto que contém macitentan, composição farmacêutica que o contém e uso de macitentan
CN106075455A (zh) 2008-12-30 2016-11-09 丹麦国家医院 鉴定发展成器官功能衰竭的风险提高的危重患者的方法及用于其治疗的化合物
JP5649645B2 (ja) 2009-05-07 2015-01-07 ユナイテッド セラピューティクス コーポレイション プロスタサイクリンアナログの固形製剤
WO2011005505A2 (en) 2009-06-22 2011-01-13 Johnson Matthey Public Limited Company Method for the purification of prostaglandins
PT2461812E (pt) 2009-08-07 2014-04-07 Scipharm S Rl Composição para o tratamento da fibrose cística
US9327105B2 (en) * 2010-03-26 2016-05-03 Itrace Biomedical Inc. Active transdermal drug delivery system and the method thereof
EP2552967A4 (en) 2010-04-02 2014-10-08 Amunix Operating Inc BINDING FUSION PROTEINS, BINDING FUSION PROTEIN MEDICINAL CONJUGATES, XTEN MEDICAMENT CONJUGATES, AND METHOD FOR THEIR PREPARATION AND USE
WO2011123830A2 (en) 2010-04-02 2011-10-06 Amunix Operating Inc. Alpha 1-antitrypsin compositions and methods of making and using same
WO2011134478A2 (en) 2010-04-29 2011-11-03 Thrombologic Aps Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof
CA3029711A1 (en) 2010-06-03 2011-12-08 United Therapeutics Corporation Treprostinil production
WO2012006273A1 (en) 2010-07-09 2012-01-12 United Therapeutics Corporation Combination therapies with cox-2 inhibitors and treprostinil
CA2710726C (en) 2010-07-22 2016-02-23 Alphora Research Inc. Synthesis of treprostinil and intermediates useful therein
CA2726599C (en) 2010-12-30 2017-07-25 Alphora Research Inc. Process for treprostinil salt preparation
EP2663313B1 (en) 2011-01-13 2018-08-08 SciPharm S.à r.l. Method for enhancing engraftment of haematopoetic stem cells
BR112013019335B1 (pt) 2011-02-07 2022-05-31 Scipharm Sàrl Nova composição, método para aumentar o nível de camp em um célula e combinação terapêutica, para o tratamento da fibrose cística
WO2012107364A1 (en) 2011-02-07 2012-08-16 Scipharm Sàrl Novel composition for the treatment of cystic fibrosis
KR20140053881A (ko) 2011-04-19 2014-05-08 릭스하스피탈렛 모세관 누출의 예방 및 치료를 위한 수술 동안 투여되는 프로스타시클린 및 그 유사체
CN103987704A (zh) 2011-08-05 2014-08-13 卡德尔治疗公司 类黄酮化合物
WO2013024051A1 (en) 2011-08-12 2013-02-21 Ascendis Pharma A/S Sustained release composition of prostacyclin
US20140249093A1 (en) 2011-08-12 2014-09-04 Ascendis Pharma A/S Carrier-Linked Prodrugs Having Reversible Carboxylic Ester Linkages
CA2843883C (en) * 2011-08-12 2020-04-28 Ascendis Pharma A/S Carrier-linked treprostinil prodrugs
US8524939B2 (en) 2011-08-24 2013-09-03 Chirogate International Inc. Intermediates for the synthesis of benzindene prostaglandins and preparations thereof
CN103193627B (zh) 2012-01-10 2016-04-20 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
US9387214B2 (en) 2012-01-13 2016-07-12 United Therapeutics Corporation Method of identifying therapies for pulmonary hypertension
US20150057325A1 (en) 2012-03-30 2015-02-26 Rigshospitalet Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrest
US20150087688A1 (en) 2012-04-25 2015-03-26 Ascendis Pharma A/S Prodrugs of hydroxyl-comprising drugs
SMT201700496T1 (it) 2012-06-15 2017-11-15 Scipharm Sarl Processo per la preparazione di treprostinil e suoi derivati
IN2015DN00934A (cg-RX-API-DMAC7.html) 2012-08-01 2015-06-12 United Therapeutics Corp
KR20150091170A (ko) 2012-12-07 2015-08-07 카이맨 케미칼 컴파니 인코포레이티드 프로스타사이클린 유사체의 합성 방법
US10080730B2 (en) 2013-01-09 2018-09-25 United Therapeutics Corporation Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
JP6542128B2 (ja) 2013-01-11 2019-07-10 コルセア ファーマ インコーポレイテッド トレプロスチニルのプロドラッグ
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
KR102405650B1 (ko) 2013-03-15 2022-06-03 유나이티드 세러퓨틱스 코오포레이션 트레프로스티닐의 염
ES2676447T3 (es) 2013-03-25 2018-07-19 United Therapeutics Corporation Procedimiento de fabricación de compuestos de prostaciclina con tiol de unión y formas pegiladas
JP6594857B2 (ja) 2013-04-30 2019-10-23 ユナイテッド セラピューティクス コーポレイション 放出制御製剤
WO2014203278A2 (en) 2013-06-19 2014-12-24 Msn Laboratories Private Limited NOVEL PROCESS FOR THE PREPARATION OF (1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-HEXAHYDRO-2-HYDROXY-1-[(3S)-3-HYDROXYOCTYL]-1H-BENZ[f]INDEN-5-YL]OXY]ACETIC ACID
MX382833B (es) 2013-10-25 2025-03-13 Insmed Inc Compuestos derivados de prostaciclinas, y el uso de los mismo para el tratamiento de la hipertension pulmonar
EP3068752A1 (en) 2013-11-13 2016-09-21 Cayman Chemical Company Incorporated Amine salts of a prostacyclin analog
WO2015138423A1 (en) 2014-03-11 2015-09-17 Insmed Incorporated Prostacylin compositions and methods for using the same
EP3169660A1 (en) 2014-07-16 2017-05-24 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
HU231186B1 (hu) 2014-10-08 2021-06-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás treprostinil és sói előállítására
JP6866043B2 (ja) 2014-11-18 2021-04-28 インスメッド インコーポレイテッド トレプロスチニルプロドラッグおよびトレプロスチニル誘導体プロドラッグの製造方法
TWI540121B (zh) 2014-12-01 2016-07-01 臺灣永光化學工業股份有限公司 曲前列環素二乙醇胺之合成方法及新穎中間體
CA2973147A1 (en) 2015-01-27 2016-08-04 Scipharm Sarl Composition for the treatment of hepatic veno-occlusive disease
US20160243064A1 (en) 2015-02-21 2016-08-25 Gavis Pharmaceuticals Novel oral pharmaceutical compositions of treprostinil
WO2016176555A1 (en) 2015-04-29 2016-11-03 Insmed Incorporated Prostacyclin compounds, compositions and methods of use thereof
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
KR20230119035A (ko) 2016-12-05 2023-08-14 코세어 파마 인코포레이티드 트레프로스티닐 및 이의 염의 피부 및 경피 투여

Similar Documents

Publication Publication Date Title
JP2018524304A5 (cg-RX-API-DMAC7.html)
KR102093608B1 (ko) 이미다조피리딘 화합물
ES2626390T3 (es) Moduladores del receptor gamma huérfano relacionado con retinoide (ROR-gamma) para uso en el tratamiento de enfermedades autoinmunitarias e inflamatorias
JP2016512531A5 (cg-RX-API-DMAC7.html)
JP2019094345A5 (cg-RX-API-DMAC7.html)
JP2020507589A5 (cg-RX-API-DMAC7.html)
JP6859323B2 (ja) カルボキシ置換(ヘテロ)芳香環誘導体並びにその調製方法及び使用
JP2903040B2 (ja) ピラゾロピリジン化合物の用途
JP2016519165A5 (cg-RX-API-DMAC7.html)
CN111757770B (zh) 作为gpr40激动剂的3-苯基-4-己炔酸衍生物
JP2019518050A5 (cg-RX-API-DMAC7.html)
JP2015051983A5 (cg-RX-API-DMAC7.html)
JP2011506588A5 (cg-RX-API-DMAC7.html)
JP2020520946A5 (cg-RX-API-DMAC7.html)
TWI483727B (zh) 瑞巴派特前體藥物、其製造方法及其運用
JP2012502048A5 (cg-RX-API-DMAC7.html)
JP2010090149A5 (cg-RX-API-DMAC7.html)
US10710961B2 (en) Method for preparing intermediate of 4-methoxypyrrole derivative
JP2018513832A5 (cg-RX-API-DMAC7.html)
JP2018529690A5 (cg-RX-API-DMAC7.html)
JP2016505071A5 (cg-RX-API-DMAC7.html)
JP6983416B2 (ja) エトミデート誘導体ならびにその中間体、調製方法および使用
JP2022539126A (ja) ベンゾジアゼピン系化合物及びその製造方法並びに医薬における作用
JP2017520528A (ja) ホルミルペプチド受容体調節物質としてのイミダゾール誘導体
CN110156674A (zh) 一种作为吲哚胺-2,3-双加氧酶抑制剂的螺环化合物